Original descriptions of Palaearctic species of the genus C. G. Thomson, 1859 (Coleoptera, Chrysomelidae, Donaciinae) and their translations.

Many original descriptions of beetles were published in Latin with specific idioms and technical terms, which are sometimes difficult to understand. The exact meaning of these descriptions is necessary for taxonomic and systematic research. Of the ten Palaearctic species regarded as valid three were described in English, the remaining seven in Latin, French, or German: Weise, 1898, (Scopoli, 1772), (Schrank, 1781), Weise, 1912, (Kunze, 1818), (Linnaeus, 1758), and (Duvivier, 1885).

Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.

The pathological accumulation of RNA-binding proteins (RBPs) within inclusion bodies is a hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). RBP aggregation results in both toxic gain and loss of normal function. Determining the protein binding partners and normal functions of disease-associated RBPs is necessary to fully understand molecular mechanisms of RBPs in disease.

RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules.

The aggregation of RNA-binding proteins is a pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). RBM45 is an RNA-binding protein that forms cytoplasmic inclusions in neurons and glia in ALS and FTLD. To explore the role of RBM45 in ALS and FTLD, we examined the contribution of the protein's domains to its function, subcellular localization, and interaction with itself and ALS-linked proteins.

A Phase I study of LGD1069 in adults with advanced cancer.

LGD1069 [Targretin; 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl) propenyl] benzoic acid] is a novel synthetic retinoid X receptor-selective retinoid that has been recently identified. The goals of this study were to determine the safety, toxicity, pharmacokinetics (PKs), and metabolic profile of LGD1069 in advanced cancer patients. Sixty patients received oral LGD1069 at doses ranging from 5-1000 mg/m2/day with PK sampling performed on days 1 and 15.

Why does the central nervous system not regenerate after injury?

Spinal cord injuries in humans and in other mammals are never followed by regrowth. In recent years, considerable progress has been made in analyzing mechanisms that promote and inhibit regeneration. The focus of this review is changes that occur in the transition period in development when the central nervous system (CNS) changes from being able to regenerate to the adult state of failure.

Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension.

The effect of magnesium supplementation on blood pressure, erythrocyte cation metabolism, and serum lipids was evaluated in 13 patients with mild hypertension. After randomization and a 3-wk placebo run-in period, seven patients received 40 mmol Mg aspartate (20 mmol elemental Mg twice daily) and six received placebo for 3 mo. In comparison with placebo treatment, magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism.

A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients.

1. Nine severe rapid cycling manic-depressive patients were treated with a magnesium preparation, Magnesiocard 40 mEq/day in an open label study for a period up to 32 weeks. 2.

Respite care for mentally ill patients and their families.

An inpatient psychiatric unit at a Veterans Administration Medical Center offers regularly scheduled psychiatric respite care, an intervention intended to reduce recidivism among chronic patients who live with a family member and to support the family in their caregiving role. Patients and their families have the option of arranging for respite admissions for two to seven days at six- to eight-week intervals. Preliminary one-year data for 14 patients show that with participation in the respite program, subsequent hospital days are significantly decreased.